ACE2 |
Angiotensin-converting enzyme 2 receptor |
BR mt |
Brazilian mutation (gamma) |
CD1 |
Connector domain |
CH |
Central helix |
COVID-19 |
Coronavirus disease 2019 |
CQ |
Chloroquine |
cryo-EM |
Cryo-electron microscopy |
CT |
Cytoplasmic tail |
CT1 |
C-terminal domain 1 |
CT2 |
C-terminal domain 2 |
EVOO |
Extra virgin olive oil |
FP |
Fusion peptide |
FPR |
Fusion peptide region |
GISAID |
Global Initiative for Sharing All Influenza Data |
H-bond |
Hydrogen bond |
HCQ |
Hydroxychloroquine |
Hph |
Hydrophobic |
HR1 |
Heptad repeat 1 domain |
HR2 |
Heptad repeat 2 domain |
MD |
Molecular dynamics |
mt, Mt |
Mutated, mutant |
NAbs |
Neutralizing antibodies |
NAG |
N-linked glycans |
NTD |
N-terminal domain |
OC |
Oleocanthal |
OEU |
Oleuropein |
PDB |
Protein Data Bank |
PhD-SNP |
Predictor of effect on human health |
RBD |
Receptor-binding domain |
RBM |
Receptor-binding motif |
RSV |
Respiratory syncytial virus |
S protein |
Spike glycoprotein |
SA mt |
South African mutation (beta) |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
TM |
Transmembrane domain |
VOC |
Variants of concern |
wt, Wt |
Wild-type |